NU Skin Enterprises (NUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1995 | |
| Cash Flows From Operating Activities | |
| Net Income | 40,211 |
| Depreciation Amortization | 2,012 |
| Other Working Capital | 22,748 |
| Other Operating Activity | 12 |
| Operating Cash Flow | $64,983 |
| Cash Flows From Investing Activities | |
| PPE Investments | -5,374 |
| Other Investing Activity | -679 |
| Investing Cash Flow | $-6,053 |
| Cash Flows From Financing Activities | |
| Dividend Paid | -12,170 |
| Other Financing Activity | 3,250 |
| Financing Cash Flow | $-8,920 |
| Exchange Rate Effect | -3,085 |
| Beginning Cash Position | 16,288 |
| End Cash Position | 63,213 |
| Net Cash Flow | $46,925 |
| Free Cash Flow | |
| Operating Cash Flow | 64,983 |
| Free Cash Flow | 64,983 |